Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma - Quaterly Results
Date: 28-05-2025
The company witnessed a 19.96% growth in the revenue at Rs. 11574.00 millions for the quarter ended March 2025 as compared to Rs. 9648.00 millions during the year-ago period.A slim rise of 22.63% was recorded in the Net profit for the quarter ended March 2025 to Rs. 4281.00 millions From Rs. 3491.00 millions.Operating profit surged to 6233.00 millions from the corresponding previous quarter of 4886.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 11574.00 | 9648.00 | 19.96 | 40945.00 | 35689.00 | 14.73 | 40945.00 | 35689.00 | 14.73 |
| Other Income | 621.00 | 359.00 | 72.98 | 3213.00 | 1047.00 | 206.88 | 3213.00 | 1047.00 | 206.88 |
| PBIDT | 6233.00 | 4886.00 | 27.57 | 24656.00 | 17417.00 | 41.56 | 24656.00 | 17417.00 | 41.56 |
| Interest | 88.00 | 45.00 | 95.56 | 196.00 | 145.00 | 35.17 | 196.00 | 145.00 | 35.17 |
| PBDT | 6145.00 | 4841.00 | 26.94 | 24460.00 | 17272.00 | 41.62 | 24460.00 | 17272.00 | 41.62 |
| Depreciation | 937.00 | 516.00 | 81.59 | 2200.00 | 1719.00 | 27.98 | 2200.00 | 1719.00 | 27.98 |
| PBT | 5208.00 | 4325.00 | 20.42 | 22260.00 | 15553.00 | 43.12 | 22260.00 | 15553.00 | 43.12 |
| TAX | 927.00 | 834.00 | 11.15 | 3756.00 | 2487.00 | 51.03 | 3756.00 | 2487.00 | 51.03 |
| Deferred Tax | -67.00 | -2.00 | 3250.00 | -319.00 | -361.00 | -11.63 | -319.00 | -361.00 | -11.63 |
| PAT | 4281.00 | 3491.00 | 22.63 | 18504.00 | 13066.00 | 41.62 | 18504.00 | 13066.00 | 41.62 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 53.85 | 50.64 | 6.34 | 60.22 | 48.80 | 23.39 | 60.22 | 48.80 | 23.39 |